
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0 | 0 | 0 |
Shares | 100 | 100 | 0 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21 | 15 |
Price to Book | 4 | 2 |
Price to Sales | 3 | 1 |
Price to Cash Flow | 16 | 9 |
Dividend Yield | 1 | 3 |
5 Years Earnings Growth | 12 | 9 |
Name | Net % | Category Average |
---|---|---|
Technology | 33 | 9 |
Financial Services | 14 | 21 |
Healthcare | 11 | 13 |
Consumer Cyclical | 10 | 9 |
Industrials | 9 | 18 |
Communication Services | 8 | 6 |
Consumer Defensive | 6 | 11 |
Basic Materials | 3 | 6 |
Utilities | 3 | 5 |
Real Estate | 2 | 2 |
Energy | 1 | 4 |
Number of long holdings: 543
Number of short holdings: 6
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Apple | US0378331005 | 6.59 | 258.02 | +0.35% | |
Microsoft | US5949181045 | 6.00 | 517.35 | +0.31% | |
NVIDIA | US67066G1040 | 5.76 | 187.62 | -0.67% | |
Amazon.com | US0231351067 | 3.41 | 219.51 | -1.30% | |
Alphabet A | US02079K3059 | 1.96 | 245.35 | -0.14% | |
Alphabet C | US02079K1079 | 1.79 | 246.45 | +0.01% | |
Broadcom | US11135F1012 | 1.50 | 338.37 | +0.06% | |
Eli Lilly | US5324571083 | 1.47 | 839.87 | +2.44% | |
Tesla | US88160R1014 | 1.46 | 429.83 | -1.42% | |
JPMorgan | US46625H1005 | 1.25 | 310.03 | +0.81% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
NL0011309349 | 4.02B | 0.91 | 12.44 | 11.54 | ||
ACTIAM Responsible Index Fund EquNA | 2.34B | -1.32 | 12.77 | 13.69 | ||
ACTIAM Responsible Index Fund EU | 713.3M | 9.87 | 11.40 | 7.02 | ||
NL0014332579 | 392.69M | 5.06 | 8.93 | 7.06 | ||
NL0010579124 | 276.99M | 0.73 | 4.70 | 8.69 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review